Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational studyShameem Mahmood, Ashutosh Wechalekar, Frank Bridoux et al.|The Lancet Haematology|2015Cited by 153
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myelomaSally Moore, Kwee Yong, Sangeeta Atwal et al.|European Journal Of Haematology|2013Cited by 14
Risk Of Progression Of Localised Amyloidosis To Systemic Disease In 606 Patients Over 30 YearsShameem Mahmood, Ashutosh Wechalekar, Darren Foard et al.|Blood|2013Cited by 14
A Phase 1 Study of Carfilzomib-Thalidomide-Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis - Catalyst Trial ResultsMamta Garg, Ashutosh Wechalekar, Andrew Hall et al.|Blood|2019Cited by 5
Progressive Multifocal Leukoencephalopathy (PML) in 2 Patients Treated With ElranatamabOliver Tomkins, Dana Warcel, R. Maamari et al.|Clinical Lymphoma Myeloma & Leukemia|2026Cited by 1